Your browser doesn't support javascript.
loading
Leukotriene receptor antagonists enhance HCC treatment efficacy by inhibiting ADAMs and suppressing MICA shedding.
Arai, Jun; Goto, Kaku; Otoyama, Yumi; Nakajima, Yoko; Sugiura, Ikuya; Kajiwara, Atsushi; Tojo, Masayuki; Ichikawa, Yuki; Uozumi, Shojiro; Shimozuma, Yuu; Uchikoshi, Manabu; Sakaki, Masashi; Nozawa, Hisako; Nakagawa, Ryo; Muroyama, Ryosuke; Kato, Naoya; Yoshida, Hitoshi.
Afiliação
  • Arai J; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan. araiguma10@med.showa-u.ac.jp.
  • Goto K; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan. araiguma10@med.showa-u.ac.jp.
  • Otoyama Y; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nakajima Y; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Sugiura I; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Kajiwara A; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Tojo M; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Ichikawa Y; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Uozumi S; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Shimozuma Y; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Uchikoshi M; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Sakaki M; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Nozawa H; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Nakagawa R; Division of Gastroenterology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8666, Japan.
  • Muroyama R; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kato N; Department of Gastroenterology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • Yoshida H; Division of Advanced Genome Medicine, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Cancer Immunol Immunother ; 70(1): 203-213, 2021 Jan.
Article em En | MEDLINE | ID: mdl-32683508
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Carcinoma Hepatocelular / Antagonistas de Leucotrienos / Proteínas ADAM / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antígenos de Histocompatibilidade Classe I / Carcinoma Hepatocelular / Antagonistas de Leucotrienos / Proteínas ADAM / Neoplasias Hepáticas Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article